Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Archer-Daniels-Midland Company

Franklin Resources

Black Hills

Calgon Carbon

Community Trust Bancorp

Con Ed

Federal Realty Investment Trust

Illinois Tool Works

Altria

National Fuel Gas

Northwest Natural Gas

Telephone and Data Systems

United Bankshares

Universal Corp

65 Reliable 40Yr+ Dividend Hikes Reported For September

Enterprise Products Partners

Micron Technology

Mylan

Newell Brands

Omnicom Group

Ralph Lauren

Southern Company

AT&T

Wells Fargo

Exxon Mobil

It might seem odd on Main Street that the S&P 500 has managed to recapture all its losses after the panic selling seen in February and March.

11 Blue Chip Stocks That Refuse to Rally With the Market’s All-Time Highs

AbbVie

Cardinal Health

AbbVie, Cardinal Health, and Walgreens Boots Alliance are all showing growth, and each boasts a yield of at least 3.8%.

3 Ultra-High-Yield Medical Stocks That Aren't Done Growing Yet

But making Walgreens Boots Alliance an even more interesting and timely stock to look at, is the fact that in trading on Tuesday, shares of WBA entered into oversold territory, changing hands as low as $36.50 per share.

Walgreens Boots Alliance Becomes Oversold

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens today announced new offerings to support people with chronic and acute pain, including the launch of Walgreens brand diclofenac gel, an over-the-counter original prescription-strength arthritis pain relief in topical form.

Walgreens Introduces Owned Brand Arthritis Pain Relief Gel Alongside Personalized Pain Management Support

Walgreens Boots Alliance Monday named former Rite Aid CEO John Standley as president of Walgreens, saying he will lead all of the drugstore chain’s operations.

Walgreens Taps Former Rite Aid CEO Standley As President To Lead Operations

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance Appoints John Standley President of Walgreens

People's United Financial

The 4 Best Dividend Aristocrats Retirees Can Buy With The Market At All-Time Highs

Apple

Cisco Systems

CVS Health

Tesla

Vanguard High Dividend Yield ETF

As investors, there are always opportunities out there.

Dividend Stock Watch List: Lanny's September 2020 Edition

Walgreens Boots Alliance Inc (NASDAQ: WBA) has struggled in 2020, but its problems started well before the COVID-19 economic disruption.

BofA Cuts Walgreens Earnings Estimate, Says Visibility Limited On Pharmacy Chain's Growth

The U. S. move to allow pharmacists to administer seasonal flu shots to children is a precursor to an effort to quickly vaccinate Americans against the Coronavirus strain Covid-19 once a vaccine is approved by the federal government.

CVS And Walgreens Pharmacists Key To Coronavirus Vaccine Distribution

Amazon or Alphabet would be more "reflective of the modern economy" than something like Walgreens, said Todd Gordon of Ascent Wealth Partners.

The Dow should consider swapping Walgreens out for Amazon or Alphabet, trader says after shake-up

Alexion Pharma

Sirius XM Holdings Inc

Despite gaining over 33% year to date, the high-flying Nasdaq 100 still has value to offer investors.

Got $3,000? Then Buy These Bargain Nasdaq 100 Stocks

The stock price of Walgreens Boots Alliance has seen a decline of roughly 50% since the end of 2016. But, what went wrong given that Walgreens’ revenue grew 17% from 2016 to 2019?

Walgreens Stock Down 50% But Revenues Are Up 17%?

Broadcom

Exelon

Gilead Sciences

Kraft Heinz

NetApp

It took a pause Monday. Dividend investors should pay attention.

Who Said the Nasdaq Doesn't Have Dividend Stocks?

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is supporting American Red Cross relief efforts for tens of thousands of Iowans and Illinoisans still recovering from the derecho storm.

Walgreens Contributes to American Red Cross Aid for Parts of Iowa and Illinois Hit by Derecho Storm; Quickly Reopens Stores for Prescriptions and Other Essential Needs

Walgreens: It's Time To Look Into This Company Again

McDonald's

These stocks have been increasing their dividend payments for 40-plus years.

2 Dividend Aristocrats That Can Anchor Your Portfolio Even During the Coronavirus Pandemic

Archrock

Enbridge

Interpublic Group of Companies

Xerox

Investors are looking for dividend stocks in a zero interest rate environment. But these eight names may be paying out a little too much.

8 Dividend Stocks That Look Too Generous

DEERFIELD, Ill.--(BUSINESS WIRE)--With the upcoming flu season expected to coincide with the ongoing COVID-19 pandemic, Walgreens is now offering flu shots daily at all of its nearly 9,1001 pharmacies with additional safety measures in place.

Flu Shots Now Available at All Walgreens Pharmacies

U.S. drugstore chains led by Walgreens and CVS Health are rolling out an unprecedented early push for Americans to get vaccinated at their pharmacies for the seasonal flu before that virus converges with the Covid-19 pandemic

CVS, Walgreens Lead Unprecedented Flu Season Prep As Covid-19 Converges

Aflac

General Dynamics

Pfizer

Vanguard S&P 500 ETF

Dividend Stock Purchases: Bert's July Summary

Walgreens Boots Alliance Inc. WBA, -1.96% disclosed Friday that it has established a new commercial program in which the drug store chain can issue up to EUR1 billion ($1.18 bln) in short-term notes from time to time.

Walgreens sets up new program to issue up to $1.2 bln in commercial paper in euros

Healthcare Services Group

Hershey

Target

ZoomInfo Technologies reported 2Q20 results that beat Street estimates and guided 3Q20 numbers above Street.

4 Dividend Increases For The Week Of August 16th

Walgreens (WBA) reported earnings 30 days ago. What's next for the stock?

News for Walgreens Stock (WBA)